SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001867096-24-000055
Filing Date
2024-04-23
Accepted
2024-04-23 16:26:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2024proxystatementdefa14a.htm DEFA14A 12768
2 xerisnaav4_pagex1.jpg GRAPHIC 2263559
3 xerisnaav4_pagex2.jpg GRAPHIC 386968
  Complete submission text file 0001867096-24-000055.txt   3662277
Mailing Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607
Business Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607 844-445-5704
Xeris Biopharma Holdings, Inc. (Filer) CIK: 0001867096 (see all company filings)

IRS No.: 871082097 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40880 | Film No.: 24865155
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)